2008
Non-High-Density Lipoprotein Cholesterol in Patients With Metabolic Syndrome
Huang J, Parish R, Mansi I, Yu H, Kennen E, Davis T, Carden D. Non-High-Density Lipoprotein Cholesterol in Patients With Metabolic Syndrome. Journal Of Investigative Medicine 2008, 56: 931. PMID: 18753978, DOI: 10.2310/jim.0b013e318182080a.Peer-Reviewed Original ResearchConceptsNon-HDL cholesterolCoronary artery diseaseMetabolic syndromeLipoprotein cholesterolArtery diseaseMS patientsTherapeutic targetCross-sectional chart reviewLow-density lipoprotein cholesterolNon-HDL levelsCardiovascular risk factorsDensity lipoprotein cholesterolPublic hospital patientsAlternative therapeutic targetsCritical therapeutic targetExcessive hypertriglyceridemiaChart reviewLow HDLTotal cholesterolLDL cholesterolTriglyceride levelsRisk factorsHospital patientsHigh prevalencePatientsNon-High-Density Lipoprotein Cholesterol in Patients With Metabolic Syndrome
Huang J, Parish R, Mansi I, Yu H, Kennen E, Davis T, Carden D. Non-High-Density Lipoprotein Cholesterol in Patients With Metabolic Syndrome. Journal Of Investigative Medicine 2008, 56: 931. DOI: 10.231/jim.0b013e318182080a.Peer-Reviewed Original ResearchNon-HDL cholesterolCoronary artery diseaseMetabolic syndromeLipoprotein cholesterolArtery diseaseMS patientsTherapeutic targetCross-sectional chart reviewLow-density lipoprotein cholesterolNon-HDL levelsCardiovascular risk factorsDensity lipoprotein cholesterolPublic hospital patientsAlternative therapeutic targetsCritical therapeutic targetExcessive hypertriglyceridemiaChart reviewLow HDLTotal cholesterolLDL cholesterolTriglyceride levelsRisk factorsHospital patientsHigh prevalencePatients
2006
266 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE METABOLIC SYNDROME.
Huang J, Parish R, Yu H, Bass P, Mansi I, Kennen E, Davis T, Carden D. 266 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN THE METABOLIC SYNDROME. Journal Of Investigative Medicine 2006, 54: s303. DOI: 10.2310/6650.2005.x0008.265.Peer-Reviewed Original ResearchLow-density lipoprotein cholesterolHigh-density lipoprotein cholesterolLow high-density lipoprotein cholesterolMetabolic syndromeLipoprotein cholesterolCoronary artery disease preventionPrevalence of MSDiagnosis of MSPercent of patientsPrevalence of dyslipidemiaNon-HDL cholesterolDensity lipoprotein cholesterolHigher atherogenic potentialCardiovascular morbidityCentral obesityLipid managementElevated BPElevated triglyceridesHigh triglyceridesMS patientsAggressive loweringNCEP criteriaInsulin resistanceLipid therapyPatient population